No Evidence of Disease Activity in the Majority of Pediatric-Onset Multiple Sclerosis Patients Receiving RituximabNikita M. Shukla,Timothy LotzeMULTIPLE SCLEROSIS JOURNAL(2019)引用 1|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要